Mercer Global Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Mercer Global Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65	Buy	+1	New	+$55	﹤0.01%	5995

Other funds holding SBIO

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

FFASIA

FIG FINANCIAL ADVISORY SERVICES INC /ADV Oklahoma City, Oklahoma $171M AUM 27.06% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

Mercer Global Advisors's SBIO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026: 1 share worth $65. The stake represents ﹤0.01% of the portfolio and ranks #5995 among its holdings.

51 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Mercer Global Advisors held 1 share of ALPS Medical Breakthroughs ETF worth $65 as of Q2 2026.
ALPS Medical Breakthroughs ETF was a new Mercer Global Advisors position in Q2 2026.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5995 holding.
51 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.